A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

NCT04188548 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Advanced Breast Cancer
Metastatic Breast Cancer
Endometrial Cancer

Interventions

DRUG: LY3484356
DRUG: Abemaciclib
DRUG: Everolimus
DRUG: Alpelisib
DRUG: Trastuzumab
DRUG: Aromatase Inhibitor (AI)
DRUG: Pertuzumab

Sponsor

Eli Lilly and Company